BD chief George Golumbeski is the latest top exec to exit Celgene during management overhaul
Over the past decade, George Golumbeski rose to become an executive vice president at Celgene, frequently lauded for his high-profile role in leading one of the most aggressive BD teams in biotech.
But Golumbeski has quietly slipped out the back door at Celgene at a time CEO Mark Alles has been executing a series of management changes after a string of pratfalls has been raising questions about the company’s competence on executing on a longterm strategy.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.